Bioporto CEO holds Covid-19 test at arm's length: "Could be everything or nothing"

Bioporto CEO Peter Mørch Eriksen won't realize the diagnostics firm's hope of a Covid-19 home test – until the sensitivity of the product sets itself significantly apart from other tests in the market.
Bioporto CEO Peter Mørch Eriksen. | Photo: Gregers Tycho/ERH
Bioporto CEO Peter Mørch Eriksen. | Photo: Gregers Tycho/ERH
BY ULRICH QUISTGAARD, TRANSLATED BY NIELSINE NIELSEN

The Covid-19 pandemic and the world-spanning battle against it have delayed the California studies in which Danish diagnostics company Bioporto has been testing a quick saliva test for coronavirus, which people would ideally be able to bring home with them.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
!
!
Must contain at least 6 characters
!
Must contain at least 2 characters
!
Must contain at least 2 characters

Get full access for you and your coworkers

Start a free company trial today

Share article

Sign up for our newsletter

Stay ahead of development by receiving our newsletter on the latest sector knowledge.

!
Newsletter terms

Front page now

Further reading